Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
Clinical trial NCT00151320 · COMPLETED
Trial details
- NCT number
- NCT00151320
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2010-04-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.